for its HFX iQ SCS system. "Medtronic SCS device restores function in SMA trial" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this ...

SCS will contribute the most significant share to that total, around $4.6bn by 2034. Boston Scientific has 55% of the current market share, followed by Medtronic and then Abbott, as per analysis ...

Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...